latest news releases from the newsroom
Anthony W. Boor Named Interim President of Brightpoint Europe, Middle East and Africa
INDIANAPOLIS, June 15, 2009 (GLOBE NEWSWIRE) -- Brightpoint, Inc. (Nasdaq:CELL) announced today that Anthony W. Boor, Executive Vice President, Chief Financial Officer & Treasurer of Brightpoint, Inc. has been appointed the Interim President of Brightpoint Europe, Middle East and Africa (EMEA). Mr. Boor will replace Michael Koehn Milland, who has served as the President of EMEA. Mr. Boor will continue to serve as the Executive Vice President, Chief Financial Officer and Treasurer of Brightpoint, Inc. as well as serve as the Interim President of Brightpoint EMEA until a long-term President for the EMEA region has been selected.
Kiwa Bio-Tech Products Group Corporation
Kiwa Bio-Tech First Quarter 2009 Results Announced
BEIJING and CLAREMONT, Calif., June 15, 2009 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBTE) announced results for the first quarter ended March 31, 2009.
AutoChina International Ltd.
AutoChina International Limited to Begin Trading Under New Ticker Symbol
BEIJING, June 15, 2009 (GLOBE NEWSWIRE) -- AutoChina International Limited ("AutoChina" or the "Company") (formerly Spring Creek Acquisition Corp.) (OTCBB:SCRQF) (OTCBB:SCRWF) (OTCBB:SCRUF), a leading one-stop commercial vehicle financing and passenger automobile sales company in China, today announced that it will commence trading on the OTCBB under its new symbols AUCLF (common stock), AUCWF (warrants), and AUCUF (units) tomorrow morning, June 16, 2009. The Company's previous symbols were SCRQF, SCRWF, SCRUF.
Medicis Pharmaceutical Corporation
Health Canada Issues LIPOSONIX(TM) System Medical Device License
SCOTTSDALE, Ariz., June 15, 2009 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (NYSE:MRX) ("the Company"), the parent company of Medicis Technologies Corporation and Medicis Aesthetics Canada Ltd., today announced that Health Canada has issued a Medical Device License (MDL) authorizing the sale of the LIPOSONIX(TM) System Model 1 in Canada. The LIPOSONIX system is designed to utilize high intensity focused ultrasound energy to reduce subcutaneous abdominal adipose tissue in the treatment zone to provide a non-invasive, non-surgical approach to body contouring. The Company plans for the LIPOSONIX system to be marketed in Canada by Medicis Aesthetics Canada.
Credit Acceptance Corporation
Credit Acceptance Announces Extension and Modification of Credit Agreement
SOUTHFIELD, Mich., June 15, 2009 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq:CACC) (the "Company") announced today that it has extended the maturity of its credit facility with a commercial bank syndicate from June 22, 2010 to June 23, 2011. The amount of the facility was reduced from $153.5 million to $140.0 million.